EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation

Béla Merkely iD, Robert Hatala iD, Eperke Merkel iD, Mátyás Szigeti iD, Boglárka Veres iD, Alexandra Fábián iD, István Osztheimer iD, László Gellér, Michal Sasov iD, Jerzy K Wranicz iD, Csaba Földesi iD, Gábor Duray iD und 4 weitere

Europace · 02.07.2024 · 26 (7)

DOI: 10.1093/europace/euae179 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, online erschienen am 09.07.2024. Verfasst von Béla Merkely und 15 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Center, Semmelweis University, Varosmajor 68, H-1122 Budapest, Hungary. Hauptthemen laut MEDLINE: Atrial Fibrillation, Cardiac Resynchronization Therapy, Heart Failure, Stroke Volume. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BUDAPEST CRT Upgrade, Semmelweis University, Boston Scientific.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Recommendations on cardiac resynchronization therapy (CRT) in patients with atrial fibrillation or flutter (AF) are based on less robust evidence than those in sinus rhythm (SR). We aimed to assess the efficacy of CRT upgrade in the BUDAPEST-CRT Upgrade trial population by their baseline rhythm. Methods and results Heart failure patients with reduced ejection fraction (HFrEF) and previously implanted pacemaker (PM) or implantable cardioverter defibrillator (ICD) and ≥20% right ventricular (RV) pacing burden were randomized to CRT with defibrillator (CRT-D) upgrade (n = 215) or ICD (n = 145). Primary [HF hospitalization (HFH), all-cause mortality, or <15% reduction of left ventricular end-systolic volume] and secondary outcomes were investigated. At enrolment, 131 (36%) patients had AF, who had an increased risk for HFH as compared with those with SR [adjusted hazard ratio (aHR) 2.99; 95% confidence interval (CI) 1.26–7.13; P = 0.013]. The effect of CRT-D upgrade was similar in patients with AF as in those with SR [AF adjusted odds ratio (aOR) 0.06; 95% CI 0.02–0.17; P < 0.001; SR aOR 0.13; 95% CI 0.07–0.27; P < 0.001; interaction P = 0.29] during the mean follow-up time of 12.4 months. Also, it decreased the risk of HFH or all-cause mortality (aHR 0.33; 95% CI 0.16–0.70; P = 0.003; interaction P = 0.17) and improved the echocardiographic response (left ventricular end-diastolic volume difference −49.21 mL; 95% CI −69.10 to −29.32; P < 0.001; interaction P = 0.21).

Conclusion

In HFrEF patients with AF and PM/ICD with high RV pacing burden, CRT-D upgrade decreased the risk of HFH and improved reverse remodelling when compared with ICD, similar to that seen in patients in SR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCardiac Resynchronization TherapyHeart FailureStroke VolumeDefibrillators, ImplantableHumansMaleFemaleAgedTreatment OutcomeMiddle AgedVentricular Function, RightVentricular Function, LeftCardiac Resynchronization Therapy DevicesRisk FactorsHospitalizationElectric CountershockTime FactorsAged, 80 and over

Stichwörter der Autor:innen

Atrial fibrillationCardiac resynchronization therapyHeart failurePacing-induced cardiomyopathyRight ventricular pacingUpgrade

Autor:innen und Institutionen

  • Heart and Vascular Center, Semmelweis University, Varosmajor 68, H-1122 Budapest, Hungary.
  • Department of Cardiology and Angiology, National Institute of Cardiovascular Diseases, Slovak Medical University, Bratislava, Slovakia.
  • Department of Electrocardiology, Medical University of Lodz, Lodz, Poland.
  • Department of Cardiology, Gottsegen National Cardiovascular Center, Budapest, Hungary.
  • Department of Cardiology, Central Hospital of Northern Pest-Military Hospital, Budapest, Hungary.
  • Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Béla Merkely, Robert Hatala, Eperke Merkel, Mátyás Szigeti, Boglárka Veres, Alexandra Fábián, István Osztheimer, Michal Sasov, Jerzy K Wranicz, Csaba Földesi, Gábor Duray, Scott D Solomon, Valentina Kutyifa, Attila Kovács, Annamária Kosztin

Förderung

  • BUDAPEST CRT Upgrade
  • Semmelweis University
  • Boston Scientific
  • National Heart Program
  • National Research Development and Innovation Fund of Hungary
  • NVKP_16 funding scheme
  • European Union
  • Bolyai Janos Research Scholarship

Zitieren

APA

Merkely, B., Hatala, R., Merkel, E., Szigeti, M., Veres, B., Fábián, A., Osztheimer, I., Gellér, L., Sasov, M., Wranicz, J. K., Földesi, C., Duray, G., Solomon, S. D., Kutyifa, V., Kovács, A., & Kosztin, A. (2024). Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation. Europace, 26(7). https://doi.org/10.1093/europace/euae179

Vancouver

Merkely B, Hatala R, Merkel E, Szigeti M, Veres B, Fábián A, et al. Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation. Europace. 2024;26(7). doi:10.1093/europace/euae179

BibTeX
@article{Merkely2024,
  author = {Merkely, Béla and Hatala, Robert and Merkel, Eperke and Szigeti, Mátyás and Veres, Boglárka and Fábián, Alexandra and Osztheimer, István and Gellér, László and Sasov, Michal and Wranicz, Jerzy K and Földesi, Csaba and Duray, Gábor and Solomon, Scott D and Kutyifa, Valentina and Kovács, Attila and Kosztin, Annamária},
  title = {Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation},
  journal = {Europace},
  year = {2024},
  volume = {26},
  number = {7},
  doi = {10.1093/europace/euae179}
}
Kostenlos starten →